Dissertations / Theses on the topic 'Signes neurologiques'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 20 dissertations / theses for your research on the topic 'Signes neurologiques.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Mouchet-Mages, Sabine. "Corrélats structuraux des anomalies neurologiques mineures dans la schizophrénie." Paris 6, 2008. http://www.theses.fr/2008PA066345.
Gourion, David. "Stratégie phénotype-génotype dans le contexte de l'hypothèse développementale de la schizophrenie." Paris 6, 2004. http://www.theses.fr/2004PA066140.
Ferreri, Florian. "Marqueurs diagnostiques et pronostiques dans la schizophrénie : intérêt des signes neurologiques mineurs et des marqueurs lipidiques membranaires." Paris 6, 2012. http://www.theses.fr/2012PA066328.
Picard, Hernan J. "Signes neurologiques mineurs et saccades oculaires dans la schizophrénie : corrélats physiopathologiques et arguments pour une implication du cervelet." Paris 6, 2010. http://www.theses.fr/2010PA066507.
The cognitive dysmetria hypothesis of schizophrenia proposes that dysfunctions of the cortico-cerebellar-thalamo-cortical circuits (CCTC), neurodevelopmental in origin, would be the basis of the disease. We evaluated at the behavioral level, the CCTC circuits in schizophrenia, through saccadic eye tests and Neurological Soft Signs (NSS). Firstly, we studied the correlations between NSS scores and three saccadic paradigms (simple, predictive and memorized saccades) in a group of schizophrenic patients (n = 78) vs a healthy control group (n = 41) the hypothesis being that NSS scores would be correlated with saccadic abnormalities. Subsequently, we compared patients with schizophrenia (n = 23) vs healthy controls (n = 13) in a saccadic adaptation paradigm, which is very sensitive to dysfunction of the cerebellum. NSS allowed us to define more homogeneous subgroups of subjects with a high "developmental load" (SZNSS+) or a low "developmental load" (SZNSS-). Compared with controls, SZNSS+ (n = 12) had slower and incomplete saccadic adaptation, especially in its initial phase, suggesting a probable involvement of the cerebellum in the physiopathology of the disease. The overall results are discussed in light of the cognitive dysmetria hypothesis and current knowledge on the physiology of the cerebellum and eye movements. This work also highlights the importance of intermediate phenotypes (including NSS) in basic research in psychiatry
SIMON, JOSE. "Contribution a l'etude des traumatismes du rachis dorsal et lombaire sans signes neurologiques, etude multicentrique : a propos de 191 cas." Rennes 1, 1992. http://www.theses.fr/1992REN1M071.
Dervaux, Alain. "Influence de la consommation de substances sur l’émergence et l’évolution des troubles psychotiques : le cas du cannabis." Paris 6, 2010. https://tel.archives-ouvertes.fr/tel-00814790.
The higher prevalence of cannabis abuse or dependence in patients at high risk of schizophrenia, in patients with first psychotic episode, and during the course of schizophrenia patients with schizophrenia, compared with general population is well established. The reasons remain unclear and include familial vulnerability to drug use disorders, psychotomimetic effects induced by cannabis use, or personality traits. We have studied some aspects regarding vulnerability factors to cannabis use disorders in patients with schizophrenia: 1) We found that neurological soft signs scores were significantly higher in patients with cannabis dependence only, compared to healthy subjects, in particular regarding motor coordination and sensory integration 2) We found that the mean scores for impulsivity and sensation seeking were higher in a group of schizophrenia patients with lifetime cannabis abuse or dependence than in a group of schizophrenia patients without cannabis abuse or dependence 3) We assessed the role of individual sensitivity to the psychotogenic effect of cannabis among male patients with schizophrenia, and found that the first psychotic episode occurred 2. 6 years earlier in cannabis-sensitive patients compared to non cannabis-sensitive patients. A specific excess of familial history of psychotic disorder was found in these patients 4) We found that the pattern of substance use disorders found in a group of Moroccan patients with schizophrenia was different from those found in previous studies from North America or Europe, suggesting that substance use disorders could be influenced by socio-cultural context and by the availability of cannabis
Dervaux, Alain. "Influence de la consommation de substances sur l'émergence et l'évolution des troubles psychotiques." Phd thesis, Université Pierre et Marie Curie - Paris VI, 2010. http://tel.archives-ouvertes.fr/tel-00814790.
Gay, Olivier. "Marqueurs neurodéveloppementaux en psychiatrie : intérêt dans les troubles schizophréniques." Thesis, Sorbonne Paris Cité, 2016. http://www.theses.fr/2016USPCB016/document.
The term neurodevelopment in its broadest sense refers to all of the processes encompassing development of the nervous system from the earliest stages of formation in utero to later stages of maturation during adolescence to produce the fully functional adult nervous system. Work over the last thirty years has led to a neurodevelopmental model of human psychiatric disorders, including schizophrenia, based on genetic, epidemiological and imaging evidence. This model asserts that disease is fundamentally linked to or develops from abnormality(s) in the formation processes (early neurodevelopment) and maturation (late neurodevelopment) of the nervous system due to a combination of genetic and environmental factors. In this context this thesis aims to clarify the effects of neurodevelopmental abnormalities on psychiatric disorders, including schizophrenia, through the study of different markers. The first study aims to investigate correlations between markers of early brain development: a clinical marker (neurological soft signs) and an imaging marker (sulcation of the cerebral cortex) in a population of subjects with schizophrenia. A correlation between these two markers is presented: the sulcation index was found to be lower in subjects that had significant neurological soft signs. We concluded that the combined study of different markers may help to isolate subgroups of patients with greater early neurodevelopmental damage. The second study aims to characterize effects of different markers of early neurodevelopmental abnormalities on cognitive functioning in patients with schizophrenia. Effects on executive control (as measured by the Trail Making Test) were correlated with clinical markers (neurological soft signs, handedness) and imaging (sulcation of the anterior cingulate cortex and enlargment of the ventricles). We found interactions between different markers with a mainly non-linear summation effect. Our interpretation is that different markers reflect separate insults, though all early, on brain development with a common final effect on executive function. The third study aims to clarify the specificity of sulcation as a marker of early neurodevelopmental abnormalities by studying a population of adult subjects with autism spectrum disorder (ASD), a patholody beginning in early childhood and linked with evidence of early neurodevelopmental damage. Sulcation abnormalities of the anterior cingulate cortex, similar to those observed in patients with schizophrenia are detected in patients with ASD. These results suggest early neurodevelopmental abnormalities are shared by different psychiatric disorders and that changes in cortical sulcation are not specific to a given disorder but the early damage. In conclusion, we suggest that the study of neurodevelopmental abnormalities should be integrated into a dimensional approach in psychiatry
Jaafari, Nematollah. "Un TOC ou des TOC ? : apport clinique et thérapeutique à la compréhension de la psychobiologie du trouble obsessionnel compulsif." Poitiers, 2012. http://www.theses.fr/2012POIT1409.
Obsessive-compulsive disorder (OCD) as a homogeneous disease is characterized by obsessions (which cause marked anxiety or distress) and/or by compulsions (which serve to neutralize anxiety). The essential features of OCD are recurrent obsessions or compulsions that are severe enough to be time consuming (i. E they take more than 1 hour a day) or cause marked distress or significant impairment or significantly interfere with the individual’s normal routine, occupation functioning, or usual social activities or relationships with others. At some point during the course of the disorder, the person realizes that the obsessions or compulsions are excessive or unreasonable. The treatment of OCD involves a combination of psychotherapy (such as cognitivebehavioral) and pharmacological therapies (serotonergic antidepressants and neuroleptics and / or mood stabilizers). A proportion of patients (40-60%) remain symptomatic despite wellconducted treatment, and some have a form so severe that it leads to major disability and represents a public health issue. For the treatment of these resistant patients, deep brain stimulation, adaptable and reversible technique, and rTMS transcranial magnetic stimulation (rTMS) offers the opportunity for a novel therapeutic approach, based on the pathophysiology of the disease, and to selectively modulate relatively dysfunctional cortico-striato-pallidothalamo-cortical, limbic and associative, neural networks involved in the genesis of symptoms. These therapeutic techniques are effective but 10 to 20% of patients do not respond to these treatments. Our hypothesis is that, probably, OCD is a heterogeneous disease and some clinical forms do not respond to treatment. To test this hypothesis, we chose two factors: Neurological soft signs (NSS) and insight. Using the definition of OCD as a homogeneous disease, we found that NSS do occur in OCD, but without any correlation with therapeutic response. Using a heterogeneous definition of OCD, we demonstrated that patients with poor insight showed more checking behaviour and had more memory déficits. Future research will be necessary with an OCD definition as a heterogeneous disease
Duclos, Céline. "Vulnérabilité neurodéveloppementale et évolution de la schizophrénie." Paris 6, 2005. http://www.theses.fr/2005PA066401.
Martinez, Gilles. "Continuum autisme-schizophrénie : apport de l’étude de la cognition sociale et de marqueurs phénotypiques développementaux." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB065/document.
Autism and schizophrenia are both neurodevelopmental psychiatric disorders. Research on early-onset schizophrenia, commonly associated to autism spectrum disorders (ASD), suggested a possible developmental continuum between both of these disorders. Clinical and epidemiological evidence, and research from molecular genetics or brain imaging, come to support this hypothesis. In this context, social cognition is a matter of special interest. Impairments are reported both in the two disorders, but with inconsistent results, revealing common features as well as differences. Otherwise, links between social cognition impairments and neurodevelopmental burden have been until now poorly explored. Through the contribution of our three studies, we confirmed the importance of social cognition impairment in autism and schizophrenia. The MASC test (Movie for the Assessment of Social Cognition), an original tool which was by our findings validated in a French version, revealed higher overall impairment of mentalizing capabilities in ASD than in schizophrenia. Animated Shapes (non verbal test of attribution of intentions) revealed qualitative differences: whereas hypomentalizing is common both to ASD and schizophrenia, overmentalizing seemed to be more important in schizophrenia. Furthermore, along a continuum between autism and schizophrenia, social cognition impairment was linked to thought and language disorganization, and to neurological soft signs (a marker for neurodevelopmental load). In addition, in subjects with schizophrenia, overmentalizing was correlated to the precocity of onset of the disease. Altogether, our results highlight the need to screen developmental feature in adulthood. In that way, we presented preliminary results in order to validate a developmental disorders screening self-rated questionnaire. As a conclusion, our results bring evidence in favour of a hypothesis of a continuum between autism and schizophrenia, showing a social cognition impairment in both disorders, correlated to the neurodevelopmental load existing in both of them in a transnosographic way. We contributed to emphasize the sub-group of subjects with schizophrenia with early-onset of disease, characterized by a tendency to overmentalizing and presenting a marked disorganization. Our work provides avenue to further studies, integrating neuroimaging and genetic data, that will help to advance in a deeper comprehension of the pathophysiology of autism and schizophrenia. Furthermore, we used and validated in this work promising tools to improve finely psychopathological evaluation and differential diagnosis in adults suffering from autism and from schizophrenia
Mallet, Jasmina. "Marqueurs neurodéveloppementaux, cognition et facteurs environnementaux précoces et tardifs dans le phénotype psychotique des pathologies mentales Heavy cannabis use prior psychosis in schizophrenia : clinical, cognitive and neurological evidences for a new endophenotype? Etude et apport de la latéralité comme marqueur neurodéveloppemental dans les troubles schizophréniques et bipolaires Cigarette smoking and schizophrenia : a specific clinical and therapeutic profile? Results from the Face-Schizophrenia cohort Tobacco smoking is associated with antipsychotic medication, physical aggressiveness and alcohol use disorder in schizophrenia : results from the Face-SZ national cohort Tabagisme et schizophrénie, impact sur la cognition Tobacco smoking and psychotic-like experiences in a general population sample Poster congrès français de psychiatrie 2018 : Expériences psychotiques chez 50 patients adolescents hospitalisés pour la 1ère fois : approche trans-diagnostique et prospective avec la PQ16." Thesis, Sorbonne Paris Cité, 2018. https://wo.app.u-paris.fr/cgi-bin/WebObjects/TheseWeb.woa/wa/show?t=2403&f=17360.
Mental diseases represent a very heterogeneous categorical group, even within a given nosographic entity. Multifactorial approaches allow accounting for the clinical heterogeneity of mental disorders, the continuum between certain clinical dimensions, and even between the normal and the pathological. Among such dimensions, the psychotic phenotype constitutes an essential dimension of schizophrenic disorder. The dimensional approach allows for the search of psychotic experiences in most mental disorders as well as in the general population. We make the general hypothesis that certain psychiatric disorders with psychotic symptoms could be the result of the interaction between early- (obstetric traumas for example) and late- environmental factors (toxics, traumatisms) and the neurodevelopment of the individual. The initial step in this thesis work was to better define the concepts of vulnerability in psychiatry, and, based on the example of schizophrenia, to conduct a review of the literature on risk factors according to their early or late interaction with neurodevelopment. Subsequently, the first axis of research of the present thesis was to evaluate early neurodevelopmental markers (neurological soft signs, laterality, cognition). Our first work concerned the clinical, neurological and cognitive characterization of 64 patients suffering from schizophrenia, according to their cannabis use (or not) prior to psychosis. It provided evidence for a lower burden of neurodevelopment in cannabis users, and the potential impact of this substance on vulnerable individuals. Our second work concerns the clinical and cognitive impact of lateralization in patients with schizophrenia (n = 667) and bipolar disorder (n = 2445). We bring arguments for a neurodevelopmental weight (measured with this lateralization index) that is more important in schizophrenia. Our second axis of research focused on tobacco smoking as a late environmental factor in schizophrenia and psychotic phenotype. We showed in two studies on the FACE-SZ cohort (n = 361, n = 474) that SZ patients consumed almost twice as much as the general population and that they could represent a SZ subgroup with specific socio-demographic and clinical characteristics. In a third study, we compare the cognitive functions of these patients (n = 785) and show that the self-medication hypothesis alone cannot account for the high prevalence of their smoking. In a fourth work, we studied the impact of smoking on the psychotic phenotype with a dimensional approach, and showed an association between smoking and certain psychotic-type experiences in a representative sample of the US general population (NESARC, n = 34653). Finally, in a last line of research, we evaluated the psychotic phenotype in a population of adolescents and young adults hospitalized for a first psychiatric episode (n = 50). In a preliminary study, we show a high prevalence of psychotic-like experiences in these young adults, regardless of the diagnosis made six months afterwards, highlighting the trans-nosographic character of the psychotic phenotype during the emergence of different mental disorders. Overall, the present thesis underscores the clinical heterogeneity of mental illnesses and the importance of dimensional and trajectory approaches in identifying risk (or protective) factors, towards a better etiopathogenic understanding, better prevention opportunities, and a personalized patient care
Ricard, Damien. "Expression cellulaire et anatomique des protéines Ulip/CRMP dans le cerveau adulte : rôle potentiel de Ulip2 et Ulip6 dans les oligodendrocytes." Lyon 1, 2001. http://www.theses.fr/2001LYO1T050.
Belrose, Célia. "Trouble de Stress Post-Traumatique : analyser et comprendre le rétablissement pour optimiser la réinsertion : étude exploratoire auprès de militaires et civils français." Thesis, Université de Lorraine, 2020. https://docnum.univ-lorraine.fr/ulprive/DDOC_T_2020_0270_BELROSE.pdf.
Post-Traumatic Stress Disorder (PTSD) develops following a traumatic confrontation. It is characterized by a clinical tetrad: avoidance behaviors, hypervigilance, revivals and cognitivo- emotional impairments. PTSD has a prevalence of 1 to 7% in Europe (lifetime), and 20% in the military depending on the missions. The clinical course, regardless of the care, shows that more than 20% of subjects are resistant to treatment and that about 40% of subjects who recover relapse at some point. Thus, for a significant part of PTSD patients arise as a chronic disease. This finding questions the recovery mechanisms in these patients that could allow satisfactory socio-professional reintegration.Recovering process from this chronic pathology involves the interplay of psychological, cognitive and social resources. The data available in patients suffering from chronic illness point to the importance of psychological resources which allow a capacity for autonomy and social commitment. It is clear that in the context of PTSD, the psychological resources supporting recovery need further investigation. On a neurocognitive level, PTSD is characterized by executive cognitive impairment affecting in particular the memory, often associated with neurological complaints that are still little explored. These neurocognitive disorders are risk factors for chronic PTSD, impacting not only the patients' quality of life and also their socio-professional reintegration possibilities. Finally, on the social level, the course of recovery and reintegration involves satisfactory socialization. Socialization is not a linear process but it is subject to constant perpetual changes in the quality of social interactions, a key feature in this process. While the hypothesis of an impact of clinical symptoms of PTSD in the socialization of these is legitimate, the available data are scarce. This issue is all the more important for soldiers with chronic PTSD, since most of them will have to leave the military environment and re-socialize in civilian world. This doctoral work aims to better understand the psychoneurosociological mechanisms of the recovery trajectory in patients suffering from chronic PTSD. More specifically, it focuses on 4 issues. The first one is theoretical. It aims to analyze the data in the literature on recovery, and its dimensions, in chronic mental illnesses in order to propose a theoretical framework for recovery and interventionsthat could be assessed in PTSD (article 1). Three issues on the subject of field studies: a) What are the important psychological resources for the recovery and reintegration of PTSD? ; b) What are the neurological signs of interest for better understanding the evolutionary trajectory of the patient suffering from PTSD? ; and c) What are the core characteristics (pro and cons) of socialization for patients suffering from PTSD? At the end of this exploratory work, carried out mainly on soldiers suffering from chronic PTSD, we propose lines of work/evidence and recommendations for intervention to improve course of their socio-professional reintegration
Person, Christophe. "Quantification des anomalies neurologiques métaboliques et imagerie de sources électriques." Phd thesis, Université de Lorraine, 2012. http://tel.archives-ouvertes.fr/tel-00738247.
Grandbarbe, Luc. "Rôle de la voie de signalisation Notch dans la différenciation des cellules souches neurales." Université Louis Pasteur (Strasbourg) (1971-2008), 2002. http://www.theses.fr/2002STR13050.
The central nervous system comprises three major cell types: neurons, oligodendrocytes and astrocytes. All these cell-types derive from a common multipotential precursor cell, capable of self-renewing, and which is referred to as a neural stem cell. To elucidate the role of Notch signaling on the generation of neurons and glia, we made use of the in vitro neurosphère system which is clonally derived from neural stem cells through the selective action of EGF. Neurospheres prepared from Dll1lacZ mutant embryos display an increase of neurons at the expense of both oligodendrocytes and astrocytes. This mutant phenotype could be rescued when Dll1lacZ spheres were grown and/or differentiated in the presence of WT neurospheres conditioned medium. Time-dependant activation of Notch by soluble forms of ligands indicates that Notch acts in two steps. Initially, it acts on the cell fate choice by negatively regulating the neuronal fate and promoting the glial cell fate. In a second step, Notch promotes differentiation of astrocytes and inhibits differentiation of both neurons and oligodendrocytes
Baracat, Bruno. "Changements liés à l'âge dans les processus de prise de décision. Application de la théorie de la détection du signal chez l'homme adulte." Toulouse 3, 1992. http://www.theses.fr/1992TOU30255.
Hegron, Alan. "Implication des récepteurs de la mélatonine dans les troubles neurologiques et le diabète de type 2 et identification de régions clés du récepteur MT1 responsables de sa sélectivité fonctionnelle." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS555/document.
Melatonin is a neurohormone mainly released from the pineal gland in a circadian manner acting through two G protein-coupled receptors (GPCRs) called MT1 and MT2. Melatonin regulates many important physiological functions. Regulation of dopamine (DA) and glucose levels are two of them but how they do this is not clear.Extracellular DA levels are mainly regulated by its transporter (DAT) which mediates DA re-uptake into presynaptic nerve termini to prevent DA receptor hyperactivation in the presynaptic cleft. Consequently, we verified the role of DAT in the regulation of the DA system by melatonin. We showed that MT1 and MT2, by interacting with the immature non-glycosylated form of DAT retain DAT in the endoplasmic reticulum thus regulating DAT cell surface expression and DA reuptake. Consistently, mice with targeted deletion of MT1 and MT2 show markedly enhanced DA uptake in striatal synaptosomes and decreased amphetamine-induced locomotor activity. Collectively, we revealed here a molecular link between the melatonin and DA systems, which is based on the formation of a molecular complex between melatonin receptors and DAT.To better understand the role of melatonin on the regulation of glucose levels, we studied the involvement of genetic variants of MT2 in the development of type 2 diabetes (T2D). Previous studies showed that natural loss-of-function variants of MT2 associate with T2D risk. To determine more precisely the defective properties linked to T2D risk we monitored spontaneous and melatonin-induced activation of different signaling pathways by 40 MT2 variants. We show that defects in melatonin-induced Gαi and Gαz activation and spontaneous βarrestin-2 recruitment are most significantly associated to T2D risk. Experimental results correlated well with those predicted by evolutionary lineage analysis. This work will help to propose personalized treatments for MT2 variant carriers to recover their defective responses.Sequencing of 9393 individuals resulted in the identification of 32 natural MT1 variants. MT1 wild-type and variants were functionally characterized in bioluminescence resonance energy transfer (BRET) assays. We showed that MT1 activates Gαi/o, Gα12 and Gα15 proteins and recruits βarrestin-2. Analyzes of results by non-linear matrix factorization revealed the existence of 5 clusters characterized by different signaling profiles. Computational homology modeling of the 3D model of MT1 helped to determine the impact of each variant on receptor activation and interaction with G proteins and βarrestin-2. Collectively, our data illustrate that natural variants are powerful tools to understand the molecular basis of GPCR function. Overall, this work contributes to our understanding of the function of melatonin receptors and highlights their importance in the regulation of the DA system and glucose homeostasis. Our results will open new, personalized therapeutic options for patient suffering from a defective DA system or T2D
Freret-Hodara, Betty. "Rôle signalisateur du compartiment post-mitotique sur les cellules progénitrices du cortex cérébral en développement." Sorbonne Paris Cité, 2015. http://www.theses.fr/2015USPCC271.
The neocortex, recently acquired by mammals during evolution, is a highly organized structure of the cerebral cortex. Its development during neurogenesis follows a very strict temporal and spatial program of events. Neurons are sequentially generated by the proliferative and neurogenic divisions of progenitor cells. The decision to switch from proliferative to differentiative divisions is controlled by both intrinsic and extrinsic mechanisms. Notable extrinsic regulation is provided by postmitotic neurons, which exert a regulatory feedback to progenitor cells to influence this decision. Immune and vascular cells, which penetrate the cerebral cortex during early neurogenesis, are also a source of extracellular signals influencing the proliferative state of progenitor cells. Growing evidence highlights that intrauterine brain injury contributes to neurological pathologies in patients after birth. One common cause of brain injury is a lack of oxygen supply from blood vessels, leading to tell death and inflammation in the brain. We employed a murine model to study this process by generating a transgenic mouse line in which extensive tell death of cortical neurons is induced for 4 days during early embryonic development (E10. 5 to E14. 5), through the action of the diphtheria toxin. As a consequence of tell death, these mutants display a significant reduction in the number of postmitotic neurons in the cortical plate. Furthermore, an activation of microglia, immune sentinels of the brain, is observed in the area afflicted by tell death, suggesting that this results in inflammation, together with a reduction of the vascular network. To understand how this impacts brain development, we looked 4 days after the induced inflammation, at E 1 8. 5, and could observe that the number of deep-layer neurons was decreased as expected. However, interestingly, the number of superficial layer neurons was increased in the mutant. These results suggest that progenitor cells compensate for tell death by precociously proliferating/over-proliferating to produce more neurons. This was consistent with the observation of a significant increase in dividing intermediate progenitors within the germinal subventricular zone at E14. 5, as shown by EdU labeling, which fardier showed a reduction in their cell-cycle length and in their increased generation of superficial layer neurons. Furthermore, we could observe an increased number of basal radial glia cells, which comprise progenitor cells that have particularly expanded during mammalian evolution. To understand more deeply whether the microglia were mediating this phenotype, we depleted the brain of microglia. No changes were found either in intermediate progenitor proliferation or in the blood vessel network. Our data demonstrate that massive neuronal tell death results in non-tell-autonomous changes in the mode of division of the proliferative compartment and in particular in the abventricular divisions, to generate the correct number of neurons after a major hypoxie insult. Together these results demonstrate that the cerebral cortex has the capacity to compensate and to adapt in accordance with its environment and is able to recover before birth
Couture, Mélanie. "Signes neurologiques mineurs et persistants et rendement cognitif à l'âge scolaire chez des enfants à risque de difficulté d'apprentissage." Thèse, 2005. http://hdl.handle.net/1866/17637.